This bill proposes the addition of a new subsection to section 43-15.3-08 of the North Dakota Century Code, which outlines prohibited acts for drug manufacturers regarding their interactions with contract pharmacies and covered entities. The bill defines key terms such as "contract pharmacy," "covered entity," and "drug," specifically focusing on drugs purchased under reduced pricing through federal programs. It establishes that it is a class B misdemeanor for manufacturers or their affiliates to engage in certain prohibited actions, including denying or restricting the acquisition of drugs by contract pharmacies on behalf of covered entities, requiring unnecessary data submissions, and interfering with the dispensing of drugs to eligible patients.

Additionally, the bill clarifies that manufacturers cannot offer drugs in the form of rebates unless they are discounts at the time of sale and comply with federal law. However, it notes that the provisions do not apply to the limited distribution of drugs as mandated by federal regulations. This legislation aims to protect the rights of covered entities and contract pharmacies in accessing necessary medications without undue interference from manufacturers.